You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 104 No. 2, AUGUST 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (38)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Myxedema

A Reevaluation of Clinical Diagnosis Based on Eighty Cases

H. A. BLOOMER, M.D.; LAURENCE H. KYLE, M.D.

AMA Arch Intern Med. 1959;104(2):234-241.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

From the earliest descriptions of cretinism by Paracelsus1 and Platerus2 until the definitive contributions of Curling3 and Gull,4 in the late 19th century, a great morass of superstition, ignorance, and error had been gradually conquered. Correlation of thyroid atrophy found at autopsy with the clinical state, myxedema,5 and subsequent successful treatment of this condition with a glycerin extract of sheep thyroid 6,7 provided physicians with one of the most reliable approaches to the complete control of an otherwise crippling disease. It is indeed a paradox that, despite our increasing knowledge of basic thyroid physiology and the development of progressively more accurate assays of thyroid function, recent emphasis is being placed on diagnoses of "hypothyroidism" and the even more obscure entity of "idiopathic hypometabolism," while clear-cut myxedema continues to go unrecognized.

Previous reviews, by Means and Lerman 8 and by Lerman,9 have emphasized the subtle onset, diverse symptomatology, and diagnostic pitfalls . . . [Full Text PDF of this Article]


Author Affiliations

Washington, D. C.

From the Department of Medicine, Georgetown University School of Medicine and the Georgetown University Hospital. Dr. Bloomer was formerly a trainee of the National Institute of Arthritis and Metabolic Diseases, National Institutes of Health.


Footnotes

Submitted for publication Dec. 2, 1958.

Supported by the William Wade Hinshaw Cancer Research Fund.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.